Temporary Reduction of Membrane CD4 with the Antioxidant MnTBAP Is Sufficient to Prevent Immune Responses Induced by Gene Transfer
Open Access
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 14, 285-299
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Mn (III) tetrakis (4-benzoic acid) porphyrin scavenges reactive species, reduces oxidative stress, and improves functional recovery after experimental spinal cord injury in rats: comparison with methylprednisoloneBMC Neuroscience, 2013
- MyD88 Signaling in B Cells Regulates the Production of Th1-dependent Antibodies to AAVMolecular Therapy, 2012
- Revealing the role of CD4+ T cells in viral immunityJournal of Experimental Medicine, 2012
- Advances in graft-versus-host disease biology and therapyNature Reviews Immunology, 2012
- CD4 T Cells Promote CD8 T Cell Immunity at the Priming and Effector Site during Viral EncephalitisJournal of Virology, 2012
- Mechanisms of Rejection: Current PerspectivesTransplantation, 2012
- CD4 and CD8 binding to MHC molecules primarily acts to enhance Lck deliveryProceedings of the National Academy of Sciences, 2010
- Constitutively Active Lck Kinase in T Cells Drives Antigen Receptor Signal TransductionImmunity, 2010
- Endogenous TGF-β activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25-T cellsRetrovirology, 2007
- Lck Regulates the Threshold of Activation in Primary T Cells, While both Lck and Fyn Contribute to the Magnitude of the Extracellular Signal-Related Kinase ResponseMolecular and Cellular Biology, 2006